Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell linesAryan Stanley, Helmout Modjtahedi|Scientific Reports|2017Cited by 94
The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancerSaid Khelwatty, Helmout Modjtahedi|Oncotarget|2016Cited by 21
Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancerSaid Khelwatty, Helmout Modjtahedi|Oncotarget|2019Cited by 19
Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancerTanzeel Khan, Helmout Modjtahedi|Oncology Reports|2020Cited by 12
The Combination of Afatinib With Dasatinib or Miransertib Results in Synergistic Growth Inhibition of Stomach Cancer CellsTina Al-Janaby, Helmout Modjtahedi|World Journal of Oncology|2024Cited by 7